Urokinase Human, Urokinase Human, 1mg

CAT No.BT-ENZ-264

Urokinase Human, Urokinase Human, 1mg

---

Activity
1nM UK will cause a change in absorbance of 0.001 at 405nm in 1 minute at R/T in 100 ul 0.05M Tris-HCl, 0.1M NaCl, pH 7.4, using S2444 (0.6mM) as the substrate.

Contaminants
Free of: Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.

Description
Urokinase is a two-chain glycoprotein containing 411 amino acids with 12 disulfide bonds. Its molecular weight is 54,000 Dalton.

The Urokinase was lyophilized from a concentrated (1mg/ml) solution containing phosphate buffer.

Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

Purity
Greater than 90.0% as determined by SDS-PAGE.

Solubility
It is recommended to reconstitute the lyophilized Urokinase in sterile 18M¦¸-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions.

Source
Human urine.

Specific Activity
83,700IU/mg.

Stability
Lyophilized Urokinase although stable at room temperature for 3 weeks, should be stored desiccated below -18¡ãC. Upon reconstitution Urokinase should be stored at 4¡ãC between 2-7 days and for future use below -18¡ãC.
Please prevent freeze-thaw cycles.

Synonyms
Urokinase, Abbokinase, Urokinase-type Plasminogen Activator,uPA, EC 3.4.21.73, UK.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.